New England Research & Management Inc. purchased a new position in shares of M.D.C. Holdings, Inc. (NYSE:MDC) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 34,430 shares of the construction company’s stock, valued at approximately $1,098,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Amalgamated Bank purchased a new stake in M.D.C. during the 2nd quarter worth $202,000. Capital Fund Management S.A. purchased a new stake in M.D.C. during the 2nd quarter worth $223,000. Sawgrass Asset Management LLC purchased a new stake in M.D.C. during the 3rd quarter worth $262,000. Parametrica Management Ltd bought a new stake in shares of M.D.C. in the 3rd quarter worth about $285,000. Finally, Campbell & CO Investment Adviser LLC bought a new stake in shares of M.D.C. in the 3rd quarter worth about $306,000. 74.09% of the stock is currently owned by hedge funds and other institutional investors.

In other news, Director David Siegel sold 2,500 shares of M.D.C. stock in a transaction dated Friday, December 8th. The shares were sold at an average price of $31.83, for a total value of $79,575.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Herbert T. Buchwald sold 28,350 shares of M.D.C. stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $31.52, for a total transaction of $893,592.00. The disclosure for this sale can be found here. Insiders own 25.30% of the company’s stock.

M.D.C. Holdings, Inc. (NYSE:MDC) traded down $0.03 on Tuesday, hitting $34.37. 240,900 shares of the stock traded hands, compared to its average volume of 479,500. The company has a market cap of $1,930.00, a P/E ratio of 12.36, a P/E/G ratio of 1.14 and a beta of 1.38. M.D.C. Holdings, Inc. has a one year low of $25.62 and a one year high of $37.45. The company has a debt-to-equity ratio of 0.65, a current ratio of 9.45 and a quick ratio of 2.60.

M.D.C. (NYSE:MDC) last released its earnings results on Thursday, November 2nd. The construction company reported $1.16 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.61 by $0.55. M.D.C. had a net margin of 6.09% and a return on equity of 11.66%. The company had revenue of $586.30 million during the quarter, compared to the consensus estimate of $595.05 million. During the same quarter in the previous year, the firm earned $0.54 EPS. The company’s revenue was up 1.4% on a year-over-year basis. sell-side analysts expect that M.D.C. Holdings, Inc. will post 2.69 earnings per share for the current year.

Several equities research analysts have recently weighed in on the stock. UBS Group assumed coverage on shares of M.D.C. in a research report on Wednesday, October 25th. They issued a “sell” rating and a $34.00 target price for the company. Zacks Investment Research raised shares of M.D.C. from a “sell” rating to a “hold” rating in a research report on Wednesday, October 4th. Citigroup dropped their target price on shares of M.D.C. from $37.00 to $34.00 and set a “neutral” rating for the company in a research report on Friday, November 3rd. KeyCorp reissued a “hold” rating on shares of M.D.C. in a research report on Tuesday, September 26th. Finally, ValuEngine downgraded shares of M.D.C. from a “strong-buy” rating to a “buy” rating in a research report on Thursday, November 2nd. Four investment analysts have rated the stock with a sell rating, six have given a hold rating and one has assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $30.33.

TRADEMARK VIOLATION NOTICE: This report was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this report on another site, it was stolen and republished in violation of U.S. and international copyright and trademark legislation. The original version of this report can be accessed at https://www.dailypolitical.com/2018/01/09/new-england-research-management-inc-purchases-shares-of-34430-m-d-c-holdings-inc-mdc.html.

M.D.C. Profile

M.DC Holdings, Inc is engaged in two primary operations, including homebuilding and financial services. The Company’s segments include West, including segments located in Arizona, California, Nevada and Washington; Mountain, including segments located in Colorado and Utah; East, including segments located in Virginia, Florida and Maryland, which includes Pennsylvania and New Jersey; mortgage operations, including HomeAmerican Mortgage Corporation, and Other, which includes Allegiant Insurance Company, Inc, StarAmerican Insurance Ltd., American Home Insurance Agency, Inc and American Home Title and Escrow Company.

Want to see what other hedge funds are holding MDC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for M.D.C. Holdings, Inc. (NYSE:MDC).

Institutional Ownership by Quarter for M.D.C. (NYSE:MDC)

Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.